Research and experimental development on natural sciences and engineering
NORTHSEA THERAPEUTICS NORWAY AS
Revenue 2025
NOK 20.4m
Operating profit
NOK 447,000
Equity
NOK 410,000
Incorporated
2016
Employees
6
Share capital
NOK 30,000
Key figures · 2025
Current ratio
1.07
Equity ratio
6.9%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 2.2% | |
| Net margin (%%) | 1.8% | |
| Return on assets (%%) | 7.6% | |
| Likviditet | ||
| Current ratio | 1.07 | |
| Working capital | 410k | |
| Soliditet | ||
| Equity ratio (%%) | 6.9% | |
| Debt-to-equity ratio | 13.44 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.